Not exact matches
Nanodrugs,
drugs attached to tiny biocompatible particles, show great
promise in treatment
of a
number of diseases, including cancer.
Now, a study in the journal Brain describes what could be considered a direct «aquarium - to - bedside» approach, taking a
drug discovered in a genetic zebrafish model
of epilepsy and testing it, with
promising results, in a small
number of children with the disease.
«Messenger RNA therapeutics ™
promises to vastly expand the
number of diseases we can treat and usher in an entirely new era
of drug discovery and development,» said Stéphane Bancel, president and founding CEO
of Moderna.
A
promising approach for β - cell regeneration is to screen for
drugs that can increase the
number of β - cell.